References
- Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N
Engl J Med. 2015;373(16):1541-1552.
- Pulte D, Gondos A, Brenner H. Improvement in survival in younger
patients with acute lymphoblastic leukemia from the 1980s to the early
21st century. Blood. 2009;113(7):1408-1411.
- Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining
childhood and adolescent cancer mortality. Cancer.
2014;120(16):2497-2506.
- Ramanujachar R, Richards S, Hann I, Goldstone A, Mitchell C, Vora A,
Rowe J, Webb D. Adolescents with acute lymphoblastic leukaemia:
outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993)
trials. Pediatr Blood Cancer. 2007;48(3):254-261.
- Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG, Willman
CL, Fulton N, Laumann KM, Malnassy G, Paietta E, Parker E, Geyer S,
Mrózek K, Bloomfield CD, Sanford B, Marcucci G, Liedtke M, Claxton DF,
Foster MC, Bogart JA, Grecula JC, Appelbaum FR, Erba H, Litzow MR,
Tallman MS, Stone RM, Larson RA. A pediatric regimen for older
adolescents and young adults with acute lymphoblastic leukemia:
results of CALGB 10403. Blood. 2019;133(14):1548-1559.
- Ram R, Wolach O, Vidal L, Grafter-Gvili A, Shpilberg O, Raanani P.
Adolescents and Young Adults With Acute Lymphoblastic Leukemia Have a
Better Outcome When Treated With Pediatric-Inspired Regimens:
Systematic Review and Meta-Analysis. Am J Hematol. 2012;87(5):472-478.
- Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E,
Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP,
Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC,
Ifrah N, Dombret H. Pediatric-inspired therapy in adults with
Philadelphia chromosome-negative acute lymphoblastic leukemia: the
GRAALL-2003 study. J Clin Oncol. 2009;27(6):911-918.
- Horibe K, Tsukimoto I, Ohno R. Clinicopathologic characteristics of
leukemia in Japanese children and young adults. Leukemia.
2001;15(8):1256-1261.
- Pichler H, Reismüller B, Dworzak MN, Pötschger U, Urban C, Meister B,
Schmitt K, Panzer-Grümayer R, Haas OA, Attarbaschi A, Mann G. The
inferior prognosis of adolescents with acute lymphoblastic leukaemia
(ALL) is caused by a higher rate of treatment-related mortality and
not an increased relapse rate–a population-based analysis of 25
years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Br J Haematol. 2013;161(4):556-565.
- Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro
RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S,
Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung
W, Handgretinger R, Downing JR, Evans WE, Relling MV. Treating
childhood acute lymphoblastic leukemia without cranial irradiation. N
Engl J Med. 2009;360(26):2730-2741.
- Pui CH, Pei D, Campana D, Bowman WP, Sandlud JT, Kaste SC, Ribeiro RC,
Rubnitz JE, Coustan-Smith E, Jeha S, Cheng C, Metzger ML, Bhojwani D,
Inaba H, Raimondi SC, Onciu M, Howard SC, Leung W, Downing JR, Evans
WE, Relling MV. Improved prognosis for older adolescents with acute
lymphoblastic leukemia. J Clin Oncol. 2011;29(4):386-391.
- Hough R, Rowntree C, Goulden N, Mitchell C, Moorman A, Wade R, Vora A.
Efficacy and toxicity of a paediatric protocol in teenagers and young
adults with Philadelphia chromosome negative acute lymphoblastic
leukaemia: results from UKALL 2003. Br J Haematol.
2016;172(3):439-451.
- Lund B, Äsberg A, Heyman M, Kanerva J, Harila-Saari A, Hasle H,
Söderhäll S, Jónsson ÓG, Lydersen S, Schmiegelow K; Nordic Society of
Paediatric Haematology and Oncology. Risk Factors for Treatment
Related Mortality in Childhood Acute Lymphoblastic Leukaemia. Pediatr
Blood Cancer. 2011;56(4):551-559.
- Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically
documented infections and infection-related mortality in children with
acute myeloid leukemia. Blood. 2007;110(10):3532-3539.
- Kobayashi R, Hori D, Sano H, Suzuki D, Kishimoto K, Kobayashi K. Risk
Factors for Invasive Fungal Infection in Children and Adolescents With
Hematologic Malignant Diseases: A 10-year Analysis in a Single
Institute in Japan. Pediatr Infect Dis J. 2018;37(12):1282-1285.
- Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The
clinical feature of invasive fungal infection in pediatric patients
with hematologic and malignant diseases: a 10-year analysis at a
single institution at Japan. J Pediatr Hematol Oncol.
2008;30(12):886-890.
- Portugal R, Garnica M, Nucci M. Index to Predict Invasive Mold
Infection in High-Risk Neutropenic Patients Based on the Area Over the
Neutrophil Curve. J Clin Oncol. 2009;27(23):3849-3854.
- Sano H, Kobayashi R, Suzuki D, Hori D, Kishimoto K, Kobayashi K.
Impact of the D-index deduced from duration and intensity of
neutropenia following chemotherapy on the risk of invasive fungal
infection in pediatric acute myeloid leukemia. Int J Hematol.
2018;108(1):85-90.
- Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M,
Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G,
Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer
C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H,
Schrappe M; German-Austrian-Swiss ALL-BFM Study Group. Risk-adjusted
therapy of acute lymphoblastic leukemia can decrease treatment burden
and improve survival: treatment results of 2169 unselected pediatric
and adolescent patients enrolled in the trial ALL-BFM 95. Blood.
2008;111(9):4477-4489.
- Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Heerema
N, KornEL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE,
Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F,
Ungerleider R. Uniform approach to risk classification and treatment
assignment for children with acute lymphoblastic leukemia. J Clin
Oncol. 1996;14(1):18-24.
- De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T,
Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW,
Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope
WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR,
Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C,
Wingard JR, Zaoutis T, Bennett JE. Revised Definitions of Invasive
Fungal Disease from the European Organization for Research and
Treatment of Cancer/Invasive Fungal Infections Cooperative Group and
the National Institute of Allergy and Infectious Diseases Mycoses
Study Group (EURTC/MSG) Consensus Group. Clin Infect Dis.
2008;46(12):1813-1821.
- Kanda Y. Investigation of the freely available easy-to-use software
‘EZR’ for medical statistics. Bone Marrow Transplant.
2013;48(3):452-458.
- Inaba H, Pei D, Wolf J, Howard SC, Hayden RT, Go M, Varechtchouk O,
Hahn T, Buaboonnam J, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT,
Jeha S, Cheng C, Evans WE, Relling MV, Pui CH. Infection-related
complications during treatment for childhood acute lymphoblastic
leukemia. Ann Oncol. 2017;28(2):386-392.
- Johnson IS, Armstrong JG, Gorman M, Burnett JP Jr. The Vinca Alkaloid:
A New Class of Oncolytic Agents. 1963;23:1390-1427.
- Veal GJ, Hartford CM, Stewart CF. Clinical Pharmacology in the
Adolescent Oncology Patient. J Clin Oncol. 2010;28(32):4790-4799.
- Sano H, Kobayashi R, Suzuki D, Kishimoto K, Hori D, Matsushima S,
Yoshida M, Sarashina T, Toriumi N, Kobayashi K. Differential efficacy
of empirical antibiotic therapy for febrile neutropenia in
adolescent/young adult (AYA) and child patients. Int J Hematol.
2018;108(5):543-549.
- Nachman JB, La MK, Hunger SP, Heerema NA, Gaynon PS, Hastings C,
Mattano LA Jr, Sather H, Devidas M, Freyer DR, Steinherz PG, Seibel N.
Young Adults With Acute Lymphoblastic Leukemia Have an Excellent
Outcome With Chemotherapy Alone and Benefit From Intensive
Postinduction Treatment: A Report From the Children’s Oncology Group.
J Clin Oncol. 2009;27(31):5189-94.
- Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr
RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ,
Sallan SE, Silverman LB. Favorable Outcome for Adolescents With Acute
Lymphoblastic Leukemia Treated on Dana-Farver Cancer Institute Acute
Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol.
2007;25(7):813-819.
- Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro
RC, Rubnitz JE, Coustan-Smith E, Jeha S, Cheng C, Metzger ML, Bhojwani
D, Inaba H, Raimondi SC, Onciu, Howard SC, Leung W, Downing JR, Evans
WE, Relling MV. Improved Prognosis for Older Adolescents With Acute
Lymphoblastic Leukemia. J Clin Oncol. 2011;29(4):386-91.
- Larsen EC, Salzer W, Nachman J, Devidas M, Freyer DR, Raetz EA, Winick
N, Hunger SP, Carroll WL. Treatment Toxicity in adolescent and young
adult (AYA) patients compared with younger patients treated for high
risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from
the Children’s Oncology Group study AALL0232. Blood. 2011;118:1510.
- Suzuki D, Kobayashi R, Sano H, Hori D, Kobayashi K. Sarcopenia after
induction therapy in childhood acute lymphoblastic leukemia: its
clinical significance. Int J Hematol. 2018;107(4):486-489.
- O’Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, Vora A, Goulden
N, Samarasinghe S. Infection-related mortality in children with acute
lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003.
Blood. 2014;124(7):1056-61.
- O’Reilly MA, Govender D, Kirkwood AA, Vora A, Samarasinghe S, Khwaja
A, Grandage V, Rao A, Ancliff P, Pavasovic V, Cheng D, Carpenter B,
Daw S, Hough R, O’Connor D. The Incidence of Invasive Fungal
Infections in Children, Adolescents and Young Adults With Acute
lymphoblastic Leukaemia/Lymphoma Treated With the UKALL2011 Protocol:
A Multicentre Retrospective Study. Br J Haematol. 2019;186(2):327-329.
- Wang SS, Kotecha RS, Bernard A, Blyth CC, McMullan BJ, Cann MP, Yeoh
DK, Bartlett AW, Ryan AL, Moore AS, Bryant PA, Clark J, Haeusler GM.
Invasive Fungal Infections in Children With Acute Lymphoblastic
Leukaemia: Results From Four Australian Centres, 2003-2013. Pediatr
Blood Cancer. 2019;66(10):e27915.
- Rosen GP, Nielsen K, Glenn S, Abelson J, Deville J, MooreTB. Invasive
Fungal Infections in Pediatric Oncology Patients: 11-year Experience
at a Single Institution. J Pediatr Hematol Oncol. 2005;27(3):135-40.